Sanofi - Company Profile
Powered by
All the data and insights you need on Sanofi in one report.
$295
- Save hours of research time and resources with
our up-to-date Sanofi Strategy Report
- Understand Sanofi position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
View moreView up-to-date information on Sanofi patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
EP4058439A1 | Application | 5-GLIEDRIGE HETEROARYLAMINOSULFONAMIDE ZUR BEHANDLUNG VON DURCH MANGELNDE CFTR AKTIVITÄT VERMITTELTEN ERKRANKUNGEN | C07D277/52; C07D417/04; C07D417/12; C07D417/14; C07F9/6539 | September 21, 2022 |
EP4058106A1 | Application | ARZNEIMITTELABGABEVORRICHTUNG ZUR VERRINGERUNG VON DOSISMESSFEHLERN | A61M2005/2488; A61M2205/50; A61M2205/581; A61M2205/8212; A61M5/31551; A61M5/31553; A61M5/31568 | September 21, 2022 |
EP2413995B1 | Grant | DOSISKNOPF FÜR EINE ARZNEIMITTELABGABEVORRICHTUNG UND VERFAHREN ZUR HERSTELLUNG EINES DOSISKNOPFES | A61M2205/582; A61M2205/584; A61M2205/6036; A61M2205/6081; A61M37/00; A61M5/003; A61M5/20; Y10T409/303752; Y10T82/10; Y10T82/16016 | September 21, 2022 |
EP4058434A1 | Application | 6-GLIEDRIGE HETEROARYLAMINOSULFONAMIDE ZUM BEHANDELN VON KRANKHEITEN UND ZUSTÄNDEN, DIE DURCH MANGELNDE CFTR-AKTIVITÄT VERMITTELT WERDEN | A61K31/4418; A61K31/495; A61K31/496; A61K31/505; A61P11/00; A61P43/00; C07D213/75; C07D239/42; C07D239/69; C07D241/22; C07D401/12; C07D403/04; C07D403/12 | September 21, 2022 |
EP4058150A2 | Application | BIPARATOPISCHE CD73-ANTIKÖRPER | A61K2039/505; A61P35/00; C07K16/2896; C07K2317/31; C07K2317/32; C07K2317/522; C07K2317/55; C07K2317/56; C07K2317/76; C07K2317/94 | September 21, 2022 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward